Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment

NCT00610948 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: panitumumab
DRUG: everolimus
DRUG: fluorouracil
DRUG: leucovorin calcium
DRUG: oxaliplatin

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]